This Week’s Biotech Highlights
The Cross-Border Biotech Blog had a very blawg-y week this week with three posts on legal issues affecting the biotech world, thanks in part to my lovely and talented legal writer/spouse/editor/CMO Audrey Fried-Grushcow.
I kicked things off with a post on three need-to-know Canadian patent decisions that impact pharma, biotech and generics companies, pulling together three Ogilvy Renault bulletins into one executive-summary-level overview of key recent developments.
Audrey picked up the legal theme with a post noting oral arguments at the U.S. Supreme Court for a case under the False Claims Act (FCA) in which amici curiae PhRMA and . . . [more]
